 |
인쇄하기
취소
|
Eylea injection approved in Korea
Bayer HealthCare has recently received approval from the Korea Food and Drug Administration for Eylea (aflibercept) Injection for the treatment of wet age-related macular degeneration.
Eylea, known in the scientific literature as VEGF Trap-Eye and approved by the U.S. Food and Drug Administration in November 2011, is indicated for the treatment of neovascular (wet) age-related macular degen...
Eylea, known in the scientific literature as VEGF Trap-Eye and approved by the U.S. Food and Drug Administration in November 2011, is indicated for the treatment of neovascular (wet) age-related macular degen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.